Transplant/intro/induction/depleting Ab
About this set
Created by:
oogrlychkoo on March 26, 2012
Log in to favorite or report as inappropriate.
Order by
40 terms
Terms | Definitions |
|---|---|
After the introduction of these drugs, rejection rate decrease and survival rate increased | CyclosporineTacrolimus MMF Thymoglobulins Sirolimus |
In what time frame do we use LARGE doses of immunosuppressant drugs in early transplant period | From day they get new organ to 6 months |
Immunosuppressive therapy is required for how long after transplant | indefinitely |
Do we use a multi drug regimen after transplant? | yes, usually 2-3 drugs used |
When does patient receive the first dose of immunosuppressant? | Before the surgery |
What is the Induction IST: goals and target? | ![]() |
What are the guidelines for choosing IST | There are none. Based on local research results |
How many classes of drugs are available for tx? | 5 classes |
What are the drug classes for tx? | ![]() |
What is the purpose of induction therapy? | ![]() |
What type of cells re depleted in the induction therapy | T cells |
What are the significant SE from induction therapy | |
What two types of drugs do we use in Induction Therapy | Polyclonal and Monoclonal Abs |
Which of the two classes of drugs used in induction tx are non specific and deplete all T-cells | ![]() Polyclonal Antibodies |
what are the two sources of ATG? | |
What is ATG used for? | InductionRejection |
What is the MOA of ATG? | ![]() |
What are some early stage adverse effects for ATG? | ![]() |
What are some delayed AE for ATG? | ![]() |
What meds to give for the hypersensitivity of ATG early phase AE? | Acetaminophen benadryl:20-50mg solu-medrol |
What was the first Monoclonal Ab Used? | Muromonab CD3 (OKT3) |
Which Ab binds to the CD3 antigen and forms complex with the T-call receptor (TCR)? | OKT3-Muromonab CD3 |
What can OKT3 be used for? | |
Which Ab is completely from a mouse source? | OKT3-Muromonab CD3 |
What is the big problem that we have with OKT3 and reason why we don't use as often? | Cytokine Release Syndrome |
Which monoclonal Ab is no longer in the market? | Daclizumab (Zenapax) |
What is the source of Basiliximab? | Chimeric |
Which monoclonal Ab is an Interleukin 2 receptor antagonist and acts as a competitive inhibitor to the receptor? | Basiliximab |
Which Mon. Ab don't affect quiescent T cells | Basiliximab |
Which Mon. Ab is used only for induction in low risk patients? | Basiliximab |
What is the dose of Basiliximab? | |
Does Basiliximab need dose adjustment for gender or renal impairment? | |
What are some AE of Basiliximab? | ![]() Less AE than OKT3 |
What are the Induction doses and duration for ATG? | 10-20 mg/kg for 7-14 days |
WHat is the induction dose and duration for Thymoglobulin? | 1.5 mg/kg for 7-14 days |
What is the induction dose and duration for OKT3? | 5 mg for 7-14 days |
What is the induction dose for Basiliximab and the duration? | 20 mg on Day1 and Day4 |
When do we use IL2 receptor antagonists? | In INDUCTION tx |
Is IL2 receptor antagonists better tolerated than ATGs? | Yes |
Which drug class can be safely used with a low initial doses of cyclosporine? | IL2 receptor antagonists |
First Time Here?
Welcome to Quizlet, a fun, free place to study. Try these flashcards, find others to study, or make your own.







